IL148128A0 - Spherical agglomerates of telithromycin, their preparation process and their use in the preparation of pharmaceutical forms - Google Patents

Spherical agglomerates of telithromycin, their preparation process and their use in the preparation of pharmaceutical forms

Info

Publication number
IL148128A0
IL148128A0 IL14812800A IL14812800A IL148128A0 IL 148128 A0 IL148128 A0 IL 148128A0 IL 14812800 A IL14812800 A IL 14812800A IL 14812800 A IL14812800 A IL 14812800A IL 148128 A0 IL148128 A0 IL 148128A0
Authority
IL
Israel
Prior art keywords
preparation
telithromycin
pharmaceutical forms
spherical agglomerates
preparation process
Prior art date
Application number
IL14812800A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL148128(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL148128A0 publication Critical patent/IL148128A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14812800A 1999-08-26 2000-08-28 Spherical agglomerates of telithromycin, their preparation process and their use in the preparation of pharmaceutical forms IL148128A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (1)

Publication Number Publication Date
IL148128A0 true IL148128A0 (en) 2002-09-12

Family

ID=9549351

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14812800A IL148128A0 (en) 1999-08-26 2000-08-28 Spherical agglomerates of telithromycin, their preparation process and their use in the preparation of pharmaceutical forms
IL148128A IL148128A (en) 1999-08-26 2002-02-12 Preparation of globular clusters of telithromycin and their use in the preparation of pharmaceutical forms

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148128A IL148128A (en) 1999-08-26 2002-02-12 Preparation of globular clusters of telithromycin and their use in the preparation of pharmaceutical forms

Country Status (34)

Country Link
US (1) US6825218B1 (bs)
EP (1) EP1212336B1 (bs)
JP (1) JP4871467B2 (bs)
KR (1) KR100718222B1 (bs)
CN (1) CN1183151C (bs)
AR (1) AR025398A1 (bs)
AT (1) ATE255590T1 (bs)
AU (1) AU774385B2 (bs)
BR (1) BR0013569B1 (bs)
CA (1) CA2382497C (bs)
CO (1) CO5190666A1 (bs)
CZ (1) CZ2002594A3 (bs)
DE (1) DE60006976T2 (bs)
DK (1) DK1212336T3 (bs)
EA (1) EA005080B1 (bs)
ES (1) ES2209970T3 (bs)
FR (1) FR2797875B1 (bs)
HK (1) HK1049167B (bs)
HR (1) HRP20020167B1 (bs)
HU (1) HU229075B1 (bs)
IL (2) IL148128A0 (bs)
ME (2) ME00112B (bs)
MX (1) MXPA02001988A (bs)
NO (1) NO322622B1 (bs)
PL (1) PL204100B1 (bs)
PT (1) PT1212336E (bs)
RS (1) RS50433B (bs)
SI (1) SI1212336T1 (bs)
SK (1) SK287588B6 (bs)
TR (1) TR200200506T2 (bs)
TW (1) TWI272949B (bs)
UA (1) UA73523C2 (bs)
WO (1) WO2001014393A2 (bs)
ZA (1) ZA200201599B (bs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
MXPA05000322A (es) * 2002-07-19 2005-03-31 Aventis Pharma Sa Composicion oral de telitromicina con sabor enmascarado.
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
WO2004073827A1 (en) * 2003-02-21 2004-09-02 The University Of Bath Process for the production of particles
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
JP4871467B2 (ja) 2012-02-08
JP2003507484A (ja) 2003-02-25
BR0013569A (pt) 2002-05-14
ATE255590T1 (de) 2003-12-15
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
MXPA02001988A (es) 2002-08-20
HUP0202842A2 (hu) 2003-01-28
SK2532002A3 (en) 2002-09-10
UA73523C2 (uk) 2005-08-15
PL204100B1 (pl) 2009-12-31
TWI272949B (en) 2007-02-11
ES2209970T3 (es) 2004-07-01
HK1049167A1 (en) 2003-05-02
CN1371386A (zh) 2002-09-25
NO20020926L (no) 2002-02-26
YU13202A (sh) 2004-09-03
EA200200294A1 (ru) 2002-08-29
FR2797875B1 (fr) 2001-10-19
EA005080B1 (ru) 2004-10-28
DE60006976T2 (de) 2004-10-21
MEP20108A (bs) 2010-06-10
PT1212336E (pt) 2004-04-30
HK1049167B (zh) 2005-08-19
FR2797875A1 (fr) 2001-03-02
US6825218B1 (en) 2004-11-30
SK287588B6 (sk) 2011-03-04
CA2382497A1 (fr) 2001-03-01
NO322622B1 (no) 2006-11-06
KR100718222B1 (ko) 2007-05-15
CA2382497C (fr) 2011-06-28
WO2001014393A2 (fr) 2001-03-01
AR025398A1 (es) 2002-11-27
CN1183151C (zh) 2005-01-05
HU229075B1 (hu) 2013-07-29
NO20020926D0 (no) 2002-02-26
AU774385B2 (en) 2004-06-24
HRP20020167A2 (en) 2003-06-30
HUP0202842A3 (en) 2003-03-28
HRP20020167B1 (en) 2006-06-30
EP1212336B1 (fr) 2003-12-03
CO5190666A1 (es) 2002-08-29
IL148128A (en) 2006-10-31
ME00112B (me) 2010-10-10
RS50433B (sr) 2009-12-31
DE60006976D1 (de) 2004-01-15
EP1212336A2 (fr) 2002-06-12
CZ2002594A3 (cs) 2002-09-11
ZA200201599B (en) 2003-04-30
PL353137A1 (en) 2003-10-20
KR20020033771A (ko) 2002-05-07
TR200200506T2 (tr) 2002-08-21
WO2001014393A3 (fr) 2001-06-21
DK1212336T3 (da) 2004-03-15
AU7018100A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
CZ200151A3 (en) Sulfur-substituted N-arylamides of sulfonylaminocarboxylic acid, process of their preparation, their use and pharmaceutical preparations in which they are comprised
HUP0201010A3 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
ZA200204493B (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders.
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
SI1043307T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
CZ20021489A3 (cs) N-guanidinoalkylamidy, jejich příprava, pouľití a farmaceutické směsi, které je obsahují
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
PL353137A1 (en) Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms
HUP0303977A3 (en) Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical nad alimentary fields
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
HUP0102409A3 (en) Pyrimidin-aminomethhyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
PL351755A1 (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
PL371201A1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
IL163683A0 (en) Substituted 3-phenyl-5-alkoxy-1,3,4,-oxadiazol-2-ones, their preparation and use in medicaments
AU2351699A (en) The human calcium-sensing receptor in the detection and treatment of cancer
IL150237A0 (en) Benzophenone glycopyranosides, preparation and therapeutic use
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
AU2002235706A1 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder
GB0126395D0 (en) Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease
ZA200100355B (en) Pharmaceutical and/or cosmetic preparation.
HK1057706A (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed